Form 4 Tracker
Bobak R. Azamian

Director, President/CEO and Board Chair · 6 filings · Latest: Sep 4, 2026

Tarsus Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TARS
Bobak R. AzamianDirector, President/CEO and Board ChairSep 4, 2026
Sale
$90.5610,000$905.6K827,991
TARS
BOBAK AZAMIAN—Sep 4, 2026
Proposed Sale
$90.5610,000$905.6K—
TARS
Bobak R. AzamianDirector, President/CEO and Board ChairSep 2, 2026
Sale
$80.0610,000$800.6K837,991
TARS
BOBAK AZAMIAN—Sep 2, 2026
Proposed Sale
$80.0610,000$800.6K—
TARS
Bobak R. AzamianDirector, President/CEO and Board ChairJun 17, 2026
Sale
$61.5510,000$615.5K847,991
TARS
BOBAK AZAMIAN—Jun 17, 2026
Proposed Sale
$61.5510,000$615.5K—
TARS
Bobak R. AzamianDirector, President/CEO and Board ChairMar 19, 2026
Sale
$67.0011,964$801.6K33,421
TARS
Bobak R. AzamianDirector, President/CEO and Board ChairMar 18, 2026
Sale
$68.7111,667$801.6K45,385
TARS
Bobak R. AzamianDirector, President/CEO and Board ChairMar 17, 2026
Sale
$69.4210,972$761.7K57,052
TARS
Azamian Bobak R.—Mar 19, 2026
Proposed Sale
$67.0011,964$801.6K—
TARS
Azamian Bobak R.—Mar 18, 2026
Proposed Sale
$68.7111,667$801.6K—
TARS
Bobak R. AzamianDirector, President/CEO and Board ChairMar 15, 2026
Option Exercise
—66,274—68,024
TARS
Azamian Bobak R.—Mar 17, 2026
Proposed Sale
$69.4110,972$761.6K—
TARS
WILLIAM J LINK—Mar 16, 2026
Proposed Sale
$68.7812,500$859.8K—
TARS
BOBAK AZAMIAN—Dec 24, 2025
Proposed Sale
$82.516,000$495.1K—
TARS
Bobak Azamian Living Trust—Sep 24, 2025
Proposed Sale
$55.376,000$332.2K—
TARS
Azamian Bobak R.—Aug 11, 2025
Proposed Sale
$50.006,000$300.0K—
TARS
Azamian Bobak R.—Mar 24, 2025
Proposed Sale
$50.006,000$300.0K—
TARS
Azamian Bobak R.—Mar 20, 2025
Proposed Sale
$50.118,534$427.7K—
TARS
Azamian Bobak R.—Mar 19, 2025
Proposed Sale
$47.408,551$405.3K—

Page 1 of 2

Next →